TCI Wealth Advisors, Inc. - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$9,000
+200.0%
508
+69.3%
0.00%0.0%
Q2 2021$3,000
-62.5%
300
-57.1%
0.00%
-66.7%
Q1 2021$8,000
-20.0%
7000.0%0.00%
-25.0%
Q4 2020$10,000
+42.9%
700
+40.0%
0.00%
+33.3%
Q3 2020$7,000
+133.3%
500
+25.0%
0.00%
+200.0%
Q2 2020$3,000
+50.0%
400
-33.3%
0.00%0.0%
Q1 2020$2,0006000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 701,138$4,067,0000.67%
Matrix Capital Management Company, LP 2,288,560$13,274,0000.33%
NEA Management Company, LLC 1,250,000$7,250,0000.31%
Stanley-Laman Group, Ltd. 139,403$809,0000.20%
Cormorant Asset Management, LP 500,000$2,900,0000.19%
Tekla Capital Management LLC 468,399$2,717,0000.10%
Wealth Alliance Advisory Group, LLC 21,800$126,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$1,007,0000.03%
Artal Group S.A. 150,000$870,0000.02%
Baker Brothers Advisors 505,262$2,931,0000.02%
View complete list of TRILLIUM THERAPEUTICS INC shareholders